Scanner corps entier basse dose d’une fibrodysplasie ossifiante progressive
暂无分享，去创建一个
[1] D. Amiras,et al. Imaging in myeloma with focus on advanced imaging techniques. , 2019, The British journal of radiology.
[2] R. Pignolo,et al. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable. , 2017, Bone.
[3] F. Meloni,et al. Low-dose computed tomography with 4th-generation iterative reconstruction algorithm in assessment of oncologic patients , 2017, World journal of gastrointestinal oncology.
[4] H. Goldschmidt,et al. Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group , 2017, Blood Cancer Journal.
[5] Ragini Singh,et al. The stone man disease: fibrodysplasia ossificans progressiva: imaging revisited , 2012, BMJ Case Reports.
[6] A. Blum,et al. Réduction de dose dans l’exploration du rachis lombaire grâce au scanner 320-détecteurs : étude initiale , 2010 .
[7] Reinhard Vonthein,et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. , 2005, European journal of radiology.
[8] C. Job-Deslandre. Inherited ossifying diseases. , 2004, Joint, bone, spine : revue du rhumatisme.
[9] N. Müller,et al. Low-dose high-resolution CT of lung parenchyma. , 1991, Radiology.